BioCentury
ARTICLE | Company News

EVT, Hydra target deal

September 21, 2004 7:00 AM UTC

Evotec (FSE:EVT) partnered with Hydra (Cambridge, Mass.) to identify novel active compounds against an ion channel target from Hydra. EVT will develop assays and perform high throughput screening to i...